• Sodium Overload Impairs Mitochondrial Metabolism via NECSO M

  2026-06-03

  Qiao et al. reveal that sodium influx, mediated by TRPM4, triggers necrosis by disrupting mitochondrial energy metabolism. This work clarifies the NECSO pathway, linking sodium overload to impaired oxidative phosphorylation and cell death, and informs future approaches for studying metabolic cell injury.

• Spatial Control of mTORC1 Unveils Nuclear Roles in Transcrip

  2026-06-03

  This study introduces TerminaTOR, a genetically encoded tool for subcellular targeting of mTORC1 inhibition, revealing distinct transcriptional roles for nuclear mTORC1. The findings significantly advance understanding of spatial compartmentalization in mTORC1 signaling and its implications for gene regulation.

• Nuclear Export Inhibition Strategies in Triple-Negative Brea

  2026-06-02

  This study systematically identified and validated nuclear export inhibitor-based drug combinations for triple-negative breast cancer (TNBC), highlighting KPT-330 (Selinexor) as a synergistic agent in preclinical models. The findings support targeted approaches to overcome chemoresistance in aggressive breast cancer subtypes and inform combination therapy design.

• Puromycin dihydrochloride: Technical Guide for Selection & T

  2026-06-02

  Puromycin dihydrochloride is a trusted aminonucleoside antibiotic for rapid selection of eukaryotic and prokaryotic cell lines expressing the pac gene and for probing translation processes. This compound is ideal where precise, rapid protein synthesis inhibition is required, but is not recommended for applications needing long-term solution stability or where organisms lack pac gene compatibility.

• SN-38 Inhibits FUBP1–FUSE Interaction: Dual Mechanism in Can

  2026-06-01

  This study uncovers that 7-Ethyl-10-hydroxycamptothecin (SN-38), beyond inhibiting DNA topoisomerase I, directly disrupts the oncogenic FUBP1–FUSE transcriptional interaction in cancer cells. These findings reveal a previously unappreciated dual mechanism, broadening the molecular rationale for SN-38 use in advanced cancer research, particularly in models of hepatocellular and colon carcinoma.

• Ribociclib Succinate: Precision Cell Cycle Inhibition for Ne

  2026-06-01

  Explore how LEE011 succinate, a leading CDK inhibitor, enables advanced cancer research through precise cell cycle pathway modulation and robust assay design. This article uniquely integrates clinical biomarker insights with experimental best practices for translational breakthroughs.

• Brefeldin A in Applied Cell Biology: From ER Stress to Apopt

  2026-05-31

  Brefeldin A (BFA) is a gold-standard tool for dissecting ER stress, vesicle transport, and apoptosis in cancer and endothelial models. This guide delivers actionable workflows, troubleshooting insights, and highlights the translational impact of BFA-based assays, especially for sepsis-related endothelial injury and cancer research.

• BMX Kinase Controls Lysosomal Acidification in Mtb Infection

  2026-05-30

  This study uncovers how Mycobacterium tuberculosis (Mtb) promotes its intracellular survival by hijacking host BMX kinase to phosphorylate ATP6V1E1, suppressing lysosomal acidification. These findings reveal new host-pathogen signaling mechanisms and highlight BMX kinase as a promising target for host-directed therapeutic strategies.

• ML385 NRF2 Inhibitor: Advanced Workflows for Cancer and Oste

  2026-05-29

  ML385 stands out as a selective NRF2 inhibitor essential for dissecting redox signaling and overcoming therapeutic resistance in cancer and inflammatory bone disease models. This article translates recent breakthroughs—such as ML385’s role in validating NRF2-dependent mechanisms in osteoclasts—into actionable workflows, troubleshooting strategies, and comparative insights.

• BCECF-AM: Benchmark Fluorescent Probe for Intracellular pH

  2026-05-29

  BCECF-AM is a cell-permeable fluorescent dye optimized for precise intracellular pH measurement in mammalian, plant, and microbial systems. Its ratiometric fluorescence and esterase-activated retention enable high-sensitivity live-cell pH assays. This article details its mechanism, validated protocol parameters, and key use-case boundaries.

• SN-38 Disrupts FUBP1–DNA Binding: Mechanistic Insights for C

  2026-05-28

  The referenced study reveals that 7-Ethyl-10-hydroxycamptothecin (SN-38), alongside camptothecin, inhibits FUBP1 binding to its DNA target FUSE, uncovering an additional, non-canonical mechanism beyond topoisomerase I inhibition. These findings highlight new molecular targets for advanced research in solid tumors, especially hepatocellular and colon carcinomas.

• Brefeldin A: Applied Workflows for ER Stress and Cancer Rese

  2026-05-28

  Brefeldin A (BFA) is a trusted tool for dissecting protein trafficking and apoptosis in cancer and vascular biology. This article delivers actionable protocols, troubleshooting strategies, and new insights from the latest endothelial injury research.

• Vitamin D/VDR Signaling Facilitates Endometrial Decidualizat

  2026-05-27

  This study uncovers the mechanism by which 1,25-dihydroxy vitamin D3, acting via the vitamin D receptor, directly promotes decidualization of human endometrial stromal cells. The findings highlight a dose- and VDR-dependent pathway that may have translational implications for infertility research and reproductive biology.

• Cardiogreen (Indocyanine Green): Applied Workflows and Innov

  2026-05-27

  Cardiogreen (Indocyanine Green) stands out as a gold-standard vascular dye and photosensitizer, enabling robust diagnostics and next-generation cancer therapies. This article explores practical experimental protocols, troubleshooting strategies, and the latest mechanistic insights, including synergistic immunotherapy applications. APExBIO’s high-purity Cardiogreen empowers reproducible results in both clinical and translational research.

• BMX-IN-1: Precision BMX Kinase Inhibitor for Advanced Resear

  2026-05-26

  BMX-IN-1 empowers researchers to dissect BMX-driven signaling in cancer and host-pathogen interactions with unrivaled selectivity and potency. This article details experimental workflows, applied troubleshooting, and the translational impact of BMX-IN-1, leveraging breakthroughs from recent lysosomal biology studies.

16328 records 1/1089 page Next 12345 下5页 Last page